Distinguished in Ascites

Candid A. Villanueva-Santullano

Barcelona, CT, ES 
Distinguished in Ascites
Barcelona, CT, ES 
OverviewLocationsClinical Research

Overview

Candid Villanueva-Santullano practices in Barcelona, Spain. Ms. Villanueva-Santullano is rated as a Distinguished expert by MediFind in the treatment of Ascites. Her top areas of expertise are Esophageal Varices, Portal Hypertension, Gastrointestinal Bleeding, Endoscopy, and Liver Transplant.

Her clinical research consists of co-authoring 92 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 11 articles and participated in 2 clinical trials in the study of Ascites.

Gender
Female

Locations

Barcelona, CT, Spain
Other Locations
Pi, CT, Spain
Madrid, MD, Spain
Spain
La Santa, LO, Spain
Pau, CT, Spain
Lleida, CT, Spain
Fuenlabrada, MD, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II, Single-arm, Open-label Study to Characterise the Effect on Portal Pressure, the Effect on Renal Function and the Pharmacokinetic Profile of N-003 in Patients With Decompensated Cirrhosis
A Phase II, Single-arm, Open-label Study to Characterise the Effect on Portal Pressure, the Effect on Renal Function and the Pharmacokinetic Profile of N-003 in Patients With Decompensated Cirrhosis
Enrollment Status: Terminated
Publish Date: February 26, 2021
Intervention Type: Drug
Study Phase: Phase 2
Multicenter, Randomized, Double-blind, Placebo-controlled Study on the Effectiveness of Treatment With Beta-blockers to Prevent Decompensation of Cirrhosis With Portal Hypertension
Multicenter, Randomized, Double-blind, Placebo-controlled Study on the Effectiveness of Treatment With Beta-blockers to Prevent Decompensation of Cirrhosis With Portal Hypertension
Enrollment Status: Completed
Publish Date: August 22, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

92 Total Publications

Erratum to 'Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis' [J Hepatol 83 (2025) 70-80].
Erratum to 'Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis' [J Hepatol 83 (2025) 70-80].
Journal: Journal of hepatology
Published: September 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Villanueva-Santullano's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile